share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4：持股变动声明-董事 Borgeson Blake
美股sec公告 ·  07/11 16:54
Moomoo AI 已提取核心信息
On July 9, 2024, Blake Borgeson, a key figure at Recursion Pharmaceuticals, completed a sale of 11,447 shares of the company's Class A Common Stock. The transaction was carried out on the open market at a price of $7.315 per share, resulting in a total sale value of approximately $83,734.81. Following this transaction, Borgeson's direct holdings in Recursion Pharmaceuticals amount to 7,167,110 shares. The sale reflects a transaction within the normal course of trading and does not necessarily indicate a shift in the company's long-term prospects.
On July 9, 2024, Blake Borgeson, a key figure at Recursion Pharmaceuticals, completed a sale of 11,447 shares of the company's Class A Common Stock. The transaction was carried out on the open market at a price of $7.315 per share, resulting in a total sale value of approximately $83,734.81. Following this transaction, Borgeson's direct holdings in Recursion Pharmaceuticals amount to 7,167,110 shares. The sale reflects a transaction within the normal course of trading and does not necessarily indicate a shift in the company's long-term prospects.
2024年7月9日，Recursion Pharmaceuticals重要人物布雷克·博杰森以每股7.315美元的价格在公开市场上完成了对该公司A类普通股的11,447股出售，总销售价值约为83,734.81美元。在此次交易之后，博杰森在Recursion Pharmaceuticals的直接持股为7,167,110股。此次出售反映了公司正常交易过程中的一项交易，不一定意味着该公司的长期前景发生了变化。
2024年7月9日，Recursion Pharmaceuticals重要人物布雷克·博杰森以每股7.315美元的价格在公开市场上完成了对该公司A类普通股的11,447股出售，总销售价值约为83,734.81美元。在此次交易之后，博杰森在Recursion Pharmaceuticals的直接持股为7,167,110股。此次出售反映了公司正常交易过程中的一项交易，不一定意味着该公司的长期前景发生了变化。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息